XtalPi

XtalPi is an AI-driven drug discovery and development company in FreeS Fund's portfolio, grouped alongside other "cool companies" in technology-enabled sectors . The firm was already listed as a portfolio holding by 2018, when FreeS Fund described its tech bets as backing forces that drive industrial upgrading and technology's vertical applications . More recent FreeS Fund reporting frames AI-powered pharmaceutical R&D as a core thematic focus, with drug development seen as hitting systemic limits in traditional paradigms that AI could help breach . While the bundle does not detail XtalPi's specific business model or funding history, its placement suggests it sits at the intersection of AI and biotech — a space FreeS Fund has tracked closely, including through coverage of companies like Helixon and 剂泰科技 that similarly apply AI to drug pipelines .